Turkiye Klinikleri Journal of Medical Sciences

.: ORIGINAL RESEARCH
Assessment of Physical Lung Dose-Volume Parameters in Patients Receiving Split Course Radiation Therapy for Advanced-Stage Non Small Cell Lung Cancer: Dosimetric Effect of Active Breathing Control and Clinical Implications: Analytical Research, Case-Control
İleri Küçük Hücreli Olmayan Akciğer Kanserinde Split Kurs Radyasyon Tedavisi Alan Hastalarda Fiziksel Akciğer Doz-Hacim Parametrelerinin Değerlendirilmesi: Analitik Araştırma, Vaka-Kontrol
Esin GÜNDEMa, Yelda ELÇİMa
aDepartment of Radiation Oncology, Gülhane Training and Research Hospital University of Health Sciences, Gülhane Medical Faculty, Ankara, Türkiye
Turkiye Klinikleri J Med Sci. 2022;42(4):275-81
doi: 10.5336/medsci.2022-90110
Article Language: EN
Full Text
ABSTRACT
 Objective: Active breathing control (ABC) system serves as a viable technique for the management of respiratory motion by providing reproducible breath-holding. Herein, we assess physical lung dose-volume parameters of V20 (total lung volume receiving ≥20 Gy) and mean total lung dose (MLD) in a series of patients receiving split course radiation therapy (SCRT) for advanced-stage non-small cell lung cancer (NSCLC) with the incorporation of the ABC system. Material and Methods: A series of 22 patients receiving ABC-guided SCRT for advanced-stage NSCLC were evaluated for physical lung dose-volume parameters of V20 and MLD. Two different radiation therapy plans have been generated for every patient with and without the incorporation of the ABC system to investigate the dosimetric impact. Results: Mean V20 and MLD were 32.3% and 2,104 cGy, respectively at freebreathing. Mean V20 and MLD were 24.7% and 1,697 cGy, respectively with the incorporation of the ABC system. The decrease in V20 and MLD was 23.53% and 19.34%, respectively. Conclusion: Our study shows improved normal lung tissue sparing by incorporation of ABC system in SCRT of advanced-stage NSCLC. The reduction in V20 and MLD may have clinical implications. Improved normal lung tissue sparing by use of the ABC system may result in an improved toxicity profile of radiation delivery and thereby enable dose escalation in selected patients. Admittedly, clinical follow-up of patients should be performed to elucidate clinical reflections of dosimetric gains achieved by the ABC system.

Keywords: Advanced-stage non-small cell lung cancer; split course radiation therapy; active breathing control
ÖZET
 Amaç: Aktif solunum kontrolü (ABC) sistemi, tekrarlanabilir nefes tutmayı sağlayarak solunum hareketinin yönetimi için uygun bir teknik olarak görev yapar. Burada, ileri evre küçük hücreli dışı akciğer kanseri (KHDAK) için split kurs radyasyon tedavisi [split course radiation therapy (SCRT)] alan bir dizi hastada V20'nin (≥20 Gy alan total akciğer hacmi) ve ortalama total akciğer dozunun [mean total lung dose (MLD)] fiziksel akciğer dozu-hacim parametreleri, ABC sistemi dâhil edilerek değerlendirilmiştir. Gereç ve Yöntemler: İlerlemiş KHDAK için ABC kılavuzlu SCRT uygulanan 22 hastada, fiziksel akciğer dozhacim parametreleri olan V20 ve MLD değerleri karşılaştırılmıştır. Dozimetrik etkiyi araştırmak için her hasta için, ABC sistemi dâhil olan ve olmayan 2 farklı radyasyon tedavisi planı oluşturulmuştur. Bulgular: Serbest solunumda ortalama V20 ve MLD sırasıyla %32,3 ve 2,104 cGy idi. ABC sisteminin dâhil edilmesiyle ortalama V20 ve MLD, sırasıyla %24,7 ve 1,697 cGy olmuştur. V20 ve MLD'deki düşüş sırasıyla %23,53 ve %19,34 olarak bulunmuştur. Sonuç: Çalışmamız, ileri evre KHDAK'nin SCRT tedavisine ABC sisteminin dâhil edilmesiyle normal akciğer dokusunun daha iyi korunduğunu göstermektedir. V20 ve MLD'deki azalmanın klinik sonuçlara etkisi olabilir. ABC sisteminin kullanılması, normal akciğer doku korumasında artış, radyoterapiye bağlı toksisite profilinde iyileşme ve seçilmiş hastalarda doz eskalasyonu ile sonuçlanabilir. ABC sisteminin sağladığı dozimetrik kazanımların kliniğe yansımalarını aydınlatmak için hastaların klinik takibi mutlaka yapılmalıdır.

Anahtar Kelimeler: İleri evre küçük hücreli olmayan akciğer kanseri; split kurs radyasyon tedavisi; aktif solunum kontrolü
REFERENCES:
  1. Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584-90. [Crossref]  [PubMed]  [PMC] 
  2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7-33. [Crossref]  [PubMed] 
  3. Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383(7):640-9. [Crossref]  [PubMed]  [PMC] 
  4. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584-94. [Crossref]  [PubMed]  [PMC] 
  5. Sager O, Dincoglan F, Demiral S, Gamsiz H, Uysal B, Ozcan F, et al. Optimal timing of thoracic irradiation for limited stage small cell lung cancer: current evidence and future prospects. World J Clin Oncol. 2022;13(2):116-24. [Crossref]  [PubMed]  [PMC] 
  6. Demiral S, Sager O, Dincoglan F, Uysal B, Gamsiz H, Elcim Y, et al. Evaluation of breathing-adapted radiation therapy for right-sided early stage breast cancer patients. Indian J Cancer. 2021;58(2):195-200. [PubMed] 
  7. Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Ozcan F, et al. Adaptive radiation therapy of breast cancer by repeated imaging during irradiation. World J Radiol. 2020;12(5):68-75. [Crossref]  [PubMed]  [PMC] 
  8. Sager O, Dincoglan F, Uysal B, Demiral S, Gamsiz H, Elcim Y, et al. Evaluation of adaptive radiotherapy (ART) by use of replanning the tumor bed boost with repeated computed tomography (CT) simulation after whole breast irradiation (WBI) for breast cancer patients having clinically evident seroma. Jpn J Radiol. 2018;36(6):401-6. [Crossref]  [PubMed] 
  9. Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Ozcan F, et al. Breathing adapted radiation therapy for leukemia relapse in the breast: A case report. World J Clin Oncol. 2019;10(11):369-74. [Crossref]  [PubMed]  [PMC] 
  10. Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Elcim Y, et al. Utility of moleculari with 2-deoxy-2-[fluorine-18] fluoro-dglucose positron emission tomography (18F-FDG PET) for small cell lung cancer (SCLC): a radiation oncology perspective. Curr Radiopharm. 2019;12(1):4-10. [Crossref]  [PubMed] 
  11. Sager O, Beyzadeoglu M, Dincoglan F, Demiral S, Uysal B, Gamsiz H, et al. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders. Tumori. 2015;101(1):84-90. [Crossref]  [PubMed] 
  12. Özsavaş EE, Telatar Z, Dirican B, Sağer Ö, Beyzadeoğlu M. Automatic segmentation of anatomical structures from CT scans of thorax for RTP. Comput Math Methods Med. 2014;2014:472890. [Crossref]  [PubMed]  [PMC] 
  13. Dincoglan F, Beyzadeoglu M, Sager O, Oysul K, Kahya YE, Gamsiz H, et al. Dosimetric evaluation of critical organs at risk in mastectomized left-sided breast cancer radiotherapy using breath-hold technique. Tumori. 2013;99(1):76-82. [Crossref]  [PubMed] 
  14. Saǧer Ö, Dinçoǧlan F, Gamsiz H, Demiral S, Uysal B, Surenkok S, et al. Evaluation of the impact of integrated [18f]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging on staging and radiotherapy treatment volume definition of nonsmall cell lung cancer. Gulhane Med J. 2012;54(3):220-7. [Crossref] 
  15. Sager O, Beyzadeoglu M, Dincoglan F, Oysul K, Kahya YE, Gamsız H, et al. The role of active breathing control-moderate deep inspiration breath-hold (ABC-mDIBH) usage in non-mastectomized left-sided breast cancer radiotherapy: a dosimetric evaluation UHOD. Uluslararası Hematoloji-Onkoloji Dergisi. 2012;22(3):147-55. [Crossref] 
  16. Gamsiz H, Beyzadeoglu M, Sager O, Demiral S, Dincoglan F, Uysal B, et al. Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer. Tumori. 2015;101(1):98-103. [Crossref]  [PubMed] 
  17. Gamsiz H, Beyzadeoglu M, Sager O, Dincoglan F, Demiral S, Uysal B, et al. Management of pulmonary oligometastases by stereotactic body radiotherapy. Tumori. 2014;100(2):179-83. [Crossref]  [PubMed] 
  18. Sager O, Beyzadeoglu M, Dincoglan F, Oysul K, Kahya YE, Gamsiz H, et al. Evaluation of active breathing control-moderate deep inspiration breath-hold in definitive non-small cell lung cancer radiotherapy. Neoplasma. 2012;59(3):333-40. [Crossref]  [PubMed] 
  19. Wong JW, Sharpe MB, Jaffray DA, Kini VR, Robertson JM, Stromberg JS, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys. 1999;44(4):911-9. [Crossref]  [PubMed] 
  20. Panakis N, McNair HA, Christian JA, Mendes R, Symonds-Tayler JR, Knowles C, et al. Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. Radiother Oncol. 2008;87(1):65-73. [Crossref]  [PubMed] 
  21. McNair HA, Brock J, Symonds-Tayler JR, Ashley S, Eagle S, Evans PM, et al. Feasibility of the use of the Active Breathing Co ordinator (ABC) in patients receiving radical radiotherapy for non-small cell lung cancer (NSCLC). Radiother Oncol. 2009;93(3):424-9. [Crossref]  [PubMed] 
  22. Brock J, McNair HA, Panakis N, Symonds-Tayler R, Evans PM, Brada M. The use of the Active Breathing Coordinator throughout radical non-small-cell lung cancer (NSCLC) radiotherapy. Int J Radiat Oncol Biol Phys. 2011;81(2):369-75. [Crossref]  [PubMed] 
  23. Planting A, Helle P, Drings P, Dalesio O, Kirkpatrick A, McVie G, et al. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. an EORTC Lung Cancer Cooperative Group trial. Ann Oncol. 1996;7(2):139-44. [Crossref]  [PubMed] 
  24. Ulutin HC, Güden M, Oysul K, Sürenkök S, Pak Y. Split-course radiotherapy with or without concurrent or sequential chemotherapy in non-small cell lung cancer. Radiat Med. 2000;18(2):93-6. [PubMed] 
  25. Metcalfe SK, Milano MT, Bylund K, Smudzin T, Rubin P, Chen Y. Split-course palliative radiotherapy for advanced non-small cell lung cancer. J Thorac Oncol. 2010;5(2):185-90. [Crossref]  [PubMed] 
  26. Reinfuss M, Mucha-Małecka A, Walasek T, Blecharz P, Jakubowicz J, Skotnicki P, et al. Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity. Lung Cancer. 2011;71(3):344-9. [Crossref]  [PubMed] 
  27. Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, et al. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011;6(6):1079-86. [Crossref]  [PubMed] 
  28. Dandekar VK, Young J, Kiel K, Bonomi P, Fidler MJ, Batus M, et al. Efficacy and tolerability of palliative split-course thoracic chemoradiotherapy for symptomatic non-small cell lung cancer. Am J Clin Oncol. 2015;38(6):605-9. [Crossref]  [PubMed] 
  29. Bainbridge H, Dunlop A, McQuaid D, Gulliford S, Gunapala R, Ahmed M, et al. A Comparison of isotoxic dose-escalated radiotherapy in lung cancer with moderate deep ınspiration breath hold, mid-ventilation and internal target volume techniques. Clin Oncol (R Coll Radiol). 2022;34(3):151-9. [Crossref]  [PubMed] 
  30. Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, et al. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Lancet Oncol. 2022;23(1):104-14. [Crossref]  [PubMed] 
  31. Pan WY, Bian C, Zou GL, Zhang CY, Hai P, Zhao R, et al. Combing NLR, V20 and mean lung dose to predict radiation induced lung injury in patients with lung cancer treated with intensity modulated radiation therapy and chemotherapy. Oncotarget. 2017;8(46):81387-93. [Crossref]  [PubMed]  [PMC] 
  32. Ramella S, Trodella L, Mineo TC, Pompeo E, Stimato G, Gaudino D, et al. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Int J Radiat Oncol Biol Phys. 2010;76(1):110-5. [Crossref]  [PubMed] 
  33. Fujiwara M, Doi H, Igeta M, Suzuki H, Kitajima K, Tanooka M, et al. Radiation pneumonitis after volumetric modulated Arc therapy for non-small cell lung cancer. Anticancer Res. 2021;41(11):5793-802. [Crossref]  [PubMed] 
  34. Kimura T, Togami T, Takashima H, Nishiyama Y, Ohkawa M, Nagata Y. Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema. Br J Radiol. 2012;85(1010):135-41. [Crossref]  [PubMed]  [PMC] 
  35. Zhou Z, Song X, Wu A, Liu H, Wu H, Wu Q, et al. Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy. Sci Rep. 2017;7(1):2748. [Crossref]  [PubMed]  [PMC] 
  36. Wu A, Zhou Z, Song Y, Liang S, Li F. Application of a radiation pneumonitis prediction model in patients with locally advanced lung squamous cell cancer. Ann Palliat Med. 2021;10(4):4409-17. [Crossref]  [PubMed] 

.: Up To Date

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com